1. [Clinical recommendations for treating and monitoring patients with renal cancer].
- Author
-
Petković M, Vrdoljak E, Ruzić IP, Belev B, Omrcen T, Ledina D, Tomek R, Ruzić B, Situm M, Buća A, and Pisac VP
- Subjects
- Carcinoma, Renal Cell pathology, Humans, Carcinoma, Renal Cell diagnosis, Carcinoma, Renal Cell therapy, Kidney Neoplasms diagnosis, Kidney Neoplasms therapy
- Abstract
Clear cell renal carcinoma is the most common kidney cancer. It is generally asymptomatic. A small percentage of patients present with hematuria, flank pain and abdominal mass. It is usually detected accidentally during radiologic examination. The diagnosis of kidney cancer is confirmed by pathohistological findings after completion of the diagnostic process. The decision about treatment is made based on clinical assessment of disease stage and other risk factors. Depending on that, treatment options include surgery, and considering high resistance of kidney cancer on chemotherapy and hormone therapy, use of targeted therapies (immunotherapy, tyrosine kinase inhibitors) and palliative radiotherapy. The following text presents the clinical guidelines in order to standardize procedures and criteria for the diagnosis, management, treatment and monitoring of patients with kidney cancer in the Republic of Croatia.
- Published
- 2012